Diagnosis of RSTS: Identification of the Acetylation Profiles as Epigenetic Markers for Assessing Causality of CREBBP and EP300 Variants.
Condition(s):Rubinstein-Taybi SyndromeLast Updated:January 17, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Rubinstein-Taybi SyndromeLast Updated:January 17, 2024Recruiting
Condition(s):Patients With Recurrent or Refractory Multiple MyelomaLast Updated:May 11, 2018Unknown status
Condition(s):Type 2 Diabetes Mellitus; ObesityLast Updated:October 27, 2017Unknown status
Condition(s):Head and Neck Squamous Cell CarcinomaLast Updated:February 1, 2018Completed
Condition(s):Healthy VolunteersLast Updated:March 18, 2014Completed
Condition(s):Colorectal CancerLast Updated:May 21, 2019Unknown status
Condition(s):Histone Deacetylase (HDAC) ActivityLast Updated:April 30, 2019Terminated
Condition(s):CancerLast Updated:July 20, 2016Terminated
Condition(s):Colorectal CancerLast Updated:May 5, 2014Unknown status
Condition(s):TuberculosisLast Updated:October 2, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.